• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415
Citation: XIE Weina, DING Qi, SUN Jing, ZHANG Chaofeng, ZHANG Mian, XU Xianghong. Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice[J]. Journal of China Pharmaceutical University, 2018, 49(4): 483-489. DOI: 10.11665/j.issn.1000-5048.20180415
shu

Protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice

More Information
    Graphical Abstract
    • Abstract
  • This study aimed to investigate the protective effects of Baibu Tang on bleomycin-induced pulmonary fibrosis in mice. After intratracheally giving bleomycin(3. 5 mg/kg), mice were orally administered Baibu Tang once a day for 14 consecutive days, takingnintedanib as a positive control. The anti-fibrotic effects were assessed by the hydroxyproline level and the histopathological changes in H&E or Masson stained lung tissues. The results revealed that the lung coefficient, hydroxyproline content, inflammation and collagen deposition were increased significantly in the lung tissue of the model mice. Both ethanol and water extracts of Baibu Tang significantly improved all the pathological indexes in mice, but the effect of the ethanol extract was better than that of the water extract. Baibu Tang with Baibu(root of Stemona tuberosa)containing different components(neotuberostemonine, tuberostemonine and stemoninine, respectively)could significantly reduce hydroxyproline level and collagen deposition in the lung tissue of bleomycin-induced mice, and there was no significant difference in their activity. This result showed that the changes in the chemical composition of Stemona tuberosa(Baibu, monarch drug for Baibu Tang)have little effect on the anti-fibrosis activity of Baibu Tang, and its mechanism and material basis need further investigation.
    • FullText(HTML)
    • References (16)
  • [1]
    Liang JR,Zhang YL,Xie T,et al.Hyaluronan and TLR4 promote surfactant protein C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice[J].nat Med,2016,22(11):1285-1293.
    [2]
    Park S,Lee EJ.Recent advances in idiopathic pulmonary fibrosis[J].Tuberc Respir Dis(Seoul),2013,74(1):1-6.PH
    [3]
    Divya T, Dineshbabu V, Soumyakrishnan S, et al. Celastrol enhances nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis[J].Chem Biol Interact,2016,246:52-62.
    [4]
    Hillary LK,Flaherty KR,Moore BB.Pathogenesis,current treatments and future directions for idiopathic pulmonary fibrosis[J].Curr Opin Pharmacol,2013,13(3):377-385.
    [5]
    Spagnolo P, Maher TM, Richeldi L. Idiopathic pulmonary fibrosis:recent advances on pharmacological therapy[J].Pharmacol Therapeut,2015,152:18-27.
    [6]
    Yang L,Lv XD,Liu YM,et al.Research progress on the mechanism of oxidative stress in traditional Chinese medicine on prevention and treatment of pulmonary fibrosis[J].World J Integr Tradit West Med(世界中西医结合杂志),2017,12(3):297-300.
    [7]
    Chinese Pharmacopoeia Commission.Pharmacopoeia of the People’s Republic of China(Vol 1)(中华人民共和国药典,一部)[S].Beijing:China Medical Science Press,2015:132.
    [8]
    Wang ZW,Yang PL,Shen L,et al.Clinical study of BaiBu YangFei Decocted Extract in the treatment for COPD patients at stable stage[J].West J Tradit Chin Med(西部中医药),2015,28(5):56-59.
    [9]
    Li R,Zhang Y,Chen YR.Clinical analysis of 38 cases of pulmonary fibrosis treated by tonifying kidney and activating meridians[J].J Mod Clin Med(现代临床医学),2014,40(4):285-287.
    [10]
    Xu YT,Hon PM,Jiang RW,et al.Antitussive effects of Stemona tuberosa with different chemical profiles[J].J Ethnopharmacol,2006,108(1):46-53.
    [11]
    Jiang RW,Hon PM,Zhou Y,et al.Alkaloids and Chemical Diversity of Stemona tuberosa[J].Jnat Prod,2006,69(5):749-754.
    [12]
    Hillary LK,Flaherty KR,Moore BB.Pathogenesis,current treatments and future directions for idiopathic pulmonary fibrosis[J].Curr Opin Pharmacol,2013,13(3):377-385.
    [13]
    Huang YJ,Gong JN.Analysis on pulmonary fibrosis ofname,pathogenesis,syndromes and treatment[J].J Liaoning Univ TCM(辽宁中医药大学学报),2016,18(9):98-100.
    [14]
    Gong T,Yan DD,Dou YC,et al.Research progress of traditional Chinese medicine for pulmonary fibrosis[J].J Shandong Univ TCM(山东中医药大学学报),2016,40(6):579-582.
    [15]
    Xiang J,Yu P,Li MD,et al.Protective effects of stemona alkaloids on mice with bleomycin-induced pulmonary fibrosis[J].J China Pharm Univ(中国药科大学学报),2017,48(1):76-81.
    [16]
    Xiang J,Cheng S,Feng TL,et al.neotuberostemonine attenuates bleomycin-induced pulmonary fibrosis by suppressing the recruitment and activation of macrophages[J].Int Immunopharmacol,2016,36(7):158-164.
    • Related Articles

  • Related Articles

    [1]XU Yuantao, WANG Jundong, GUAN Li, ZHAO Ning, LI Weize. Synthesis and antidiabetic activity evaluation of benzopyrimidine derivatives[J]. Journal of China Pharmaceutical University, 2023, 54(5): 569-576. DOI: 10.11665/j.issn.1000-5048.2023041701
    [2]MEI Yinliu, WU Jie. Application of nanoparticles in wound healing of diabetes[J]. Journal of China Pharmaceutical University, 2022, 53(1): 25-31. DOI: 10.11665/j.issn.1000-5048.20220104
    [3]TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315
    [4]LI Yongrong, CHENG Tao, WANG Yongsheng, LI Qin, GAO Bo, HE Yun, BAI Yu. Effect of extract of selenium-enriched Astragalus membranaceus on insulin resistance in streptozotocin-induced diabetic rats[J]. Journal of China Pharmaceutical University, 2018, 49(6): 739-745. DOI: 10.11665/j.issn.1000-5048.20180616
    [5]XU Zhimeng, ZHU Jingjing, JIANG Zhenzhou, LOU Fengchang, WANG Tao. Hypoglycemic effects of terpenes from Fructus Corni on db/db diabetic mice[J]. Journal of China Pharmaceutical University, 2016, 47(3): 337-341. DOI: 10.11665/j.issn.1000-5048.20160315
    [6]HU Mengyue, LIU Can, ZHANG Mian, HU Nan, LIU Li, LIU Xiaodong. Alteration of cytochrome P450s activity under diabetic conditions and its impact on the development of diabetes mellitus[J]. Journal of China Pharmaceutical University, 2014, 45(2): 153-160. DOI: 10.11665/j.issn.1000-5048.20140204
    [7]WANG Xin-ting, ZHANG Mian, GUO Hai-fang, LIU Can, HU Nan, LIU Li, LIU Xiao-dong. Effect and mechanism of atorvastatin on blood glucose of mild diabetic rats[J]. Journal of China Pharmaceutical University, 2012, 43(5): 453-459.
    [8]Effects of Melatonin on the Immune Functions of Diabetic Rats Combined with Injury-induced Stress[J]. Journal of China Pharmaceutical University, 2004, (4): 71-74.
    [9]PREVENTION AND TREATMENT OF ALLOXAN-INDUCED DIABETES IN MICE BY POLYSACCHARIDES ISOLATED RESPECTIVELY FROM BOTH TREMELLA FUCIFORMIS AND AURICULARIA A URICULA[J]. Journal of China Pharmaceutical University, 1989, (3): 181-183.
    [10]PREVENTION AND TREATMENT OF ALLOXAN-INDUCED DIABETES IN MICE BY POLYSACCHARIDES FROM SPORE OF TREMELLA FUCIFORMIS BERK[J]. Journal of China Pharmaceutical University, 1988, (4): 303-304.

  • Cited by

    Periodical cited type(7)

    1. 刘艳，温田田，孙野，陈庆山，张丽莉，匡海学，杨炳友. 白鲜皮化学成分研究. 中成药. 2025(03): 812-821 .
    2. 陈禹竹，徐晓敏，刘树民，卢芳. 白鲜皮及其有效成分的药理作用研究进展. 药物评价研究. 2024(02): 409-418 .
    3. 刘新月，陈乐乐，孙鹏，展照双，王加锋. 白鲜皮化学成分、药理作用和毒性研究进展及质量标志物预测分析. 中国新药杂志. 2023(08): 799-805 .
    4. 牛晨冬，郭丽娜，张金玲，卢宜然，王琳琳，李宗锴. 白鲜属植物化学成分与药理作用研究进展. 中成药. 2022(04): 1231-1238 .
    5. 葛翎，路露，周谦，张秋生，蔡波，黄晓德，张峰伦，钱雪，李海涛，陈斌，曹鹏. 马齿苋醇提物体外生物学活性测定. 中国野生植物资源. 2021(04): 8-14+21 .
    6. 梁郭智，孙淑英. 白鲜研究进展. 时珍国医国药. 2020(02): 408-411 .
    7. 胡玉恒，孙捷，杨洁，王晓静. 3-(4′-苯甲酰基氨基-苯基)-香豆素衍生物的合成及体外降血糖活性. 中国药科大学学报. 2019(02): 168-174 . 本站查看

    Other cited types(4)

Catalog

    Get Citation
    PDF
    XML
    Article views PDF downloads Cited by(11)
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：365847

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return